· Venture Capital Tracker · investment-strategies  · 1 min read

Floodgate Leads EFEX Seed, Joins Counsel Health Series A

Floodgate led a seed round for fintech EFEX and joined Counsel Health’s $25M Series A, staying active across AI and fintech seeds.

Floodgate stayed active across AI and fintech seeds, leading EFEX’s seed round (financial software) and joining Counsel Health’s $25M Series A.

Key facts

  • Investor: Floodgate (lead on EFEX; participant in Counsel Health)
  • EFEX: Seed round led by Floodgate (early 2026)
  • Counsel Health: $25M Series A (Oct 2025)
  • Firm: Micro-VC pioneer; $150K-$1M typical checks

Why this matters

The deals show Floodgate continuing to write early checks across fintech and AI-native healthcare, consistent with its bridge-between-angels-and-VC model.

Sources

  1. Floodgate / EFEX & Counsel Health (CB Insights): https://www.cbinsights.com/investor/floodgate
  2. Floodgate portfolio (Caplight): https://www.caplight.com/investor/floodgate

By Venture Capital Tracker

Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

Frequently Asked Questions

Common questions about this topic

Back to Blog

Recommended next

Browse all research »

Did Stripe Buy OpenRouter? Yes. $7.5B Is Press

Stripe and OpenRouter confirmed the acquisition on August 19, 2026. The deal is not closed. Neither company posted a price. The New York Times, via TechCrunch, reports $7.5 billion. Last verified round remains May’s $113M Series B at $1.3B.